NSE ScannerChemicals · Chemicals: Specialty · NSE: IOLCP · data 2026-10-31
IOL Chemicals & Pharmaceuticals Ltd.
In plain words
Price: 20.7% below its 52-week high of ₹224.
Delivery: 36.2% of traded shares were kept for delivery over the last 10 sessions, against 34.8% over the last 60.
Latest results: a net profit of ₹65 cr for the quarter ended Sept 2026 (+117.1% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,524 cr |
| Net profit (last 12 months) | ₹168 cr |
| Sales growth, 3 years (yearly) | 1.5% |
| Profit growth, 3 years (yearly) | -0.4% |
At a glance
Promoters 62.3% (+9.7 pts in a year), pledged 0.0%, institutions 7.5%.
P/E 31.0, dividend yield 0.6%. Price relative to earnings and book value (low is cheaper, not better).
ROE 7.9%, ROCE 9.9%, operating margin 9.1%: how much profit it earns on the money it uses.
Debt/equity 0.08, Profit growth -0.4% and sales growth 1.5% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Promoters raised their holding by 9.7 points in a year.
- Low return on equity (7.9%).
- Profit fell 0.4% a year over 3 years.
- Slow sales growth (1.5% a year over 3 years).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
IOLCP Q2 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹795.03 crore, up 40.1% YoY and up 5.1% QoQ.
Net profit was ₹65.07 crore, up 117.1% YoY and up 1% QoQ.
Operating margin was 13.8% (10.1% a year ago).
EPS was ₹2.21, up 116.7% YoY and up 0.5% QoQ.
IOLCP के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹795.03 करोड़; पिछले साल की तुलना में 40.1% की बढ़त, पिछली तिमाही की तुलना में 5.1% की बढ़त।
शुद्ध मुनाफ़ा: ₹65.07 करोड़; पिछले साल की तुलना में 117.1% की बढ़त, पिछली तिमाही की तुलना में 1% की बढ़त।
ऑपरेटिंग मार्जिन: 13.8% (एक साल पहले 10.1%)।
EPS: ₹2.21; पिछले साल की तुलना में 116.7% की बढ़त, पिछली तिमाही की तुलना में 0.5% की बढ़त।
IOLCPના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹795.03 કરોડ; ગયા વર્ષની સરખામણીએ 40.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 5.1% વધારો.
ચોખ્ખો નફો: ₹65.07 કરોડ; ગયા વર્ષની સરખામણીએ 117.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 1% વધારો.
ઓપરેટિંગ માર્જિન: 13.8% (એક વર્ષ પહેલાં 10.1%).
EPS: ₹2.21; ગયા વર્ષની સરખામણીએ 116.7% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 0.5% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
9/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 4/30: Delivery 33.9% over the last 20 sessions vs 31.6% in the 40 before (1.07x); shares delivered per day 0.65x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend ● Split
- 30 Oct 26Results Q2 FY27 results: profit +117.1% YoY
- 10 Aug 26Results Q1 FY27 results: profit +89.8% YoY -2.2% next session
- 20 May 26Results Q4 FY26 results: profit +69.2% YoY +10.0% next session
- 17 Feb 26Dividend Dividend ₹1 (ex-date) -0.9% next session
- 11 Feb 26Results Q3 FY26 results: profit +0.2% YoY -7.8% next session
- 11 Nov 25Results Q2 FY26 results: profit +56.5% YoY +10.4% next session
- 7 Aug 25Results Q1 FY26 results: profit +13.2% YoY -2.5% next session
- 17 May 25Results Q4 FY25 results: profit +13.8% YoY +1.4% next session
- 11 Mar 25Split Split: face value ₹10 → ₹2 (ex-date) -10.1% next session
- 18 Feb 25Dividend Dividend ₹4 (ex-date) -2.8% next session
- 12 Feb 25Results Q3 FY25 results: profit −11.0% YoY -4.6% next session
- 14 Nov 24Results Q2 FY25 results: profit −49.4% YoY -5.7% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | ₹795 cr | ₹65 cr | +117.1% | 13.8% | 2.21 |
| Jun 2026 | ₹756 cr | ₹64 cr | +89.8% | 13.7% | 2.2 |
| Mar 2026 | ₹619 cr | ₹53 cr | +69.2% | 14.9% | 1.81 |
| Dec 2025 | ₹580 cr | ₹21 cr | +0.2% | 9.9% | 0.7 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 62.28% | 62.28% | 57.48% | 52.62% |
| Foreign institutions (FII) | 7.25% | 4.87% | 1.72% | 2.08% |
| Domestic institutions (DII) | 0.30% | 0.43% | 0.02% | 0.03% |
| Mutual funds | 0.29% | 0.02% | 0.02% | 0.02% |
| Retail investors | 21.47% | 21.86% | 25.93% | 25.78% |
| Number of shareholders | 1,32,241 | 1,19,311 | 1,31,550 | 1,33,531 |
Common questions
What was IOL Chemicals & Pharmaceuticals Ltd.'s latest quarterly profit?
IOL Chemicals & Pharmaceuticals Ltd. reported a net profit of ₹65 cr for the quarter ended Sept 2026 (+117.1% on the same quarter a year earlier), on revenue of ₹795 cr.
How much do promoters hold in IOL Chemicals & Pharmaceuticals Ltd.?
Promoters held 62.28% of IOL Chemicals & Pharmaceuticals Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is IOL Chemicals & Pharmaceuticals Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.08, which is very low.
What is IOL Chemicals & Pharmaceuticals Ltd.'s P/E ratio?
About 31, based on the last 12 months' earnings and a price of ₹177.65 (data 2026-10-31).
What is the 52-week high and low of IOL Chemicals & Pharmaceuticals Ltd.?
The 52-week high is ₹224 and the 52-week low is ₹67.19.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| IOL Chemicals & Pharmaceuticals Ltd. | ₹177.65 | ₹5,217 cr | 31 | — | 7.9% | 9.9% | 0.08 | +87.0% |
| Balaji Amines Limited | ₹1,765.8 | ₹5,716 cr | 28 | — | 8.8% | 8.9% | 0.07 | +23.7% |
| Savita Oil Technologies Limited | ₹649.35 | ₹4,445 cr | 10.8 | — | 10.5% | 11.6% | 0 | +61.9% |
| Dhanuka Agritech Limited | ₹980.15 | ₹4,375 cr | 16.5 | — | 18.6% | 20.1% | 0.02 | -31.0% |
| Ellenbarrie Industrial Gases Limited | ₹308.45 | ₹4,346 cr | 36 | — | 14.2% | 11% | 0.19 | -32.4% |
| Laxmi Organic Industries Ltd. | ₹152.74 | ₹4,247 cr | 33.7 | — | 4.1% | 1.6% | 0.27 | -22.3% |
Compare IOLCP with BALAMINES in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open IOLCP in NSE Scanner →